Yihong Ling
机构：Sun Yat-sen University, Key Laboratory of Guangdong Province, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China · ORCID：0000-0002-6433-3213
发表论文 84 篇 · 总被引 2225 次 · h-index 27
代表论文
- Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study (2022 · Journal of Clinical Oncology · 被引 173)
- Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial (2024 · Nature Medicine · 被引 117)
- Single‐Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T‐Cell Lymphoma (2023 · Advanced Science · 被引 30)
- Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients (2023 · European Journal of Cancer · 被引 25)
- Perioperative PD-1 antibody toripalimab plus SOX or XELOX chemotherapy versus SOX or XELOX alone for locally advanced gastric or gastro-oesophageal junction cancer: Results from a prospective, randomized, open-label, phase II trial. (2023 · Journal of Clinical Oncology · 被引 20)
- Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma (2023 · Journal of Cancer Research and Clinical Oncology · 被引 11)